PAVmed Launches $9.4M ATM Facility with A.G.P. After Exhausting Prior Program
PAVM sits 17% above its 52-week low of $3.85 on light trading volume (0.4× avg).
Summary
PAVmed filed a prospectus supplement for a new $9.4 million ATM offering with A.G.P., replacing its exhausted Maxim facility. The company needs the capital to address going concern risks, but the offering will dilute existing shareholders.
Key Events · Financing and Capital Events · PAVM
-
New $9.4M ATM Facility
PAVmed entered a sales agreement with A.G.P. to sell up to $9.4 million of common stock from time to time, replacing the exhausted Maxim Group ATM.
-
Dilution Impact
At the illustrative $5.09 offering price, new investors would experience immediate dilution of $1.55 per share, based on a pro forma net tangible book value of $3.54 per share.
-
Going Concern Pressure
The offering follows Q2 2026 results showing only $3.8 million in cash and a going concern warning, making this capital raise critical for near-term operations.
-
Agent Compensation
A.G.P. will receive a 3.0% commission on gross sales, plus up to $65,000 in initial legal expense reimbursements and quarterly fees of $7,500.
Analysis · PAVM · Industrial Applications And Services
PAVmed has entered a new at-the-market sales agreement with A.G.P. for up to $9.4 million in common stock, replacing the Maxim Group facility that was fully utilized by August 13, 2026. The company faces acute cash constraints — only $3.8 million in cash as of Q2 2026 and a going concern warning — so this facility is a critical lifeline, but it comes with meaningful dilution: at the illustrative $5.09 price, new investors would be diluted by $1.55 per share immediately. The 3.0% agent commission and up to $65,000 in initial legal reimbursements are standard but add to the cost of capital.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PAVM was trading at $4.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $36.1M. The 52-week trading range was $3.85 to $28.44. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.